Skip navigation

Sumitomo Dainippon Pharma Co. Ltd.

2016 Revenue (US$ Millions)$3,520
Revenue Growth (%)2.09%
Net Income (US$ Millions)$248
Earnings Per Share (US$)NA
EPS Growth Rate (%)NA
Profit Margin7.04%
Total Equity (US$ Millions)$3,939
Return on Equity (%)6.49%
Long Term Debt (US$ Millions)$85
Debt To Equity Ratio (%)0.02%
Total Assets (US$ Millions)$6,788
Current Assets (US$ Millions)$3,219
Current Liabilities (US$ Millions)$1,953
Cost of Goods Sold (US$ Millions)$856
Inventory Turnover1.56